Mumbai-based medtech startup Bioscan Research has raised $1 million in a seed funding round led by Unicorn India Ventures, marking a significant milestone in its mission to advance non-invasive brain injury diagnostics through innovative medical technology.
The newly raised capital will support the company’s expansion into new markets, strengthen its regulatory approvals, enhance its product portfolio, and accelerate the development of new intellectual property.
Funding to Accelerate Growth and Innovation
The fresh investment will enable Bioscan Research to scale its operations while advancing its research and development initiatives.
The startup plans to utilize the funding for:
- Expanding its presence across domestic and international markets
- Securing additional regulatory approvals
- Upgrading existing medical technology products
- Developing new intellectual property (IP)
- Strengthening commercialization efforts
The funding comes at a time when demand for advanced diagnostic technologies is increasing globally, particularly for solutions that enable faster and more accurate detection of critical medical conditions.
Revolutionizing Brain Injury Detection
Founded in 2017 by Anupam Lavania and Shilpa Malik, Bioscan Research focuses on developing non-invasive medical devices designed to detect brain injuries at an early stage.
Its flagship innovation, CEREBO, leverages Near-Infrared Spectroscopy (NIRS) combined with machine learning algorithms to identify intracranial injuries without invasive procedures.
The technology is designed to assist healthcare professionals in detecting traumatic brain injuries (TBI) during the crucial treatment window, even before visible symptoms become apparent. Early diagnosis can significantly improve clinical decision-making and patient outcomes, particularly in emergency and critical care settings.
Technology Designed for Early Diagnosis
Brain injuries often require rapid diagnosis to reduce long-term complications and improve recovery outcomes. Conventional imaging methods may not always be immediately accessible in emergency situations, making portable, non-invasive diagnostic technologies increasingly valuable.
Bioscan Research’s CEREBO platform addresses this challenge by offering healthcare providers a solution that supports faster screening and timely intervention.
According to the company, the platform is designed to enhance the ability of medical professionals to identify intracranial injuries early, enabling quicker treatment decisions and potentially improving patient survival and recovery rates.
Strong Business Momentum
Bioscan Research reported fivefold (5x) growth over the past 12 months, reflecting increasing adoption of its technology within the healthcare sector.
Building on this momentum, the company aims to achieve threefold growth over the next year by expanding its customer base in India while exploring opportunities in international markets.
The startup also plans to strengthen collaborations with hospitals, healthcare institutions, and medical professionals as it scales its operations.
Growing Investor Interest in DeepTech Healthcare
The funding round was led by Unicorn India Ventures, an early-stage venture capital firm that focuses on supporting technology-driven startups.
Established in 2016, Unicorn India Ventures invests in high-growth deeptech companies operating across sectors such as:
- Artificial Intelligence (AI)
- Medical Diagnostics
- Semiconductor Technologies
- Space Technology
- AI Infrastructure
- Enterprise DeepTech
The investment reflects growing investor confidence in healthcare innovation and the increasing importance of AI-powered medical diagnostics in improving patient care.
India’s MedTech Ecosystem Continues to Expand
India’s medtech sector has witnessed rapid growth in recent years, supported by increasing investments, healthcare digitization, and advancements in artificial intelligence and medical imaging.
Innovative startups are developing solutions that improve disease detection, enable remote diagnostics, and make healthcare more accessible and efficient.
Technologies such as machine learning, portable diagnostics, and AI-assisted clinical decision-making are becoming central to the future of healthcare delivery, creating new opportunities for startups focused on medical innovation.
Looking Ahead
With fresh funding and a growing market presence, Bioscan Research is well-positioned to strengthen its role in the medical diagnostics industry. By expanding its technology platform, enhancing regulatory compliance, and entering new markets, the company aims to make early brain injury detection more accessible while contributing to better healthcare outcomes through advanced, non-invasive diagnostic solutions.
Zinnia Appoints Key Kiarie as Chief Financial Officer to Drive Next Phase of Growth
Ruchi Kumar is the associate editor at Entrepreneur News Network and TVW News India, where she leads editorial strategy, brand storytelling, and startup ecosystem coverage. With a strong focus on innovation, business, and marketing insights, he curates impactful narratives that spotlight India’s evolving entrepreneurial landscape. She has written extensively on fintech, AI and emerging startups.